Pandolfi, Franco
 Distribuzione geografica
Continente #
NA - Nord America 4.578
AS - Asia 3.673
EU - Europa 3.222
SA - Sud America 727
AF - Africa 75
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.298
Nazione #
US - Stati Uniti d'America 4.476
SG - Singapore 1.814
CN - Cina 920
DE - Germania 883
BR - Brasile 614
SE - Svezia 531
UA - Ucraina 516
FR - Francia 322
VN - Vietnam 245
IT - Italia 239
IE - Irlanda 222
FI - Finlandia 136
ID - Indonesia 134
GB - Regno Unito 128
IN - India 123
RU - Federazione Russa 95
JP - Giappone 83
HK - Hong Kong 56
TR - Turchia 52
AR - Argentina 41
BD - Bangladesh 39
IQ - Iraq 38
CA - Canada 37
MX - Messico 36
PL - Polonia 30
ZA - Sudafrica 25
NL - Olanda 24
PK - Pakistan 23
SA - Arabia Saudita 23
BE - Belgio 22
AU - Australia 18
CO - Colombia 15
ES - Italia 13
VE - Venezuela 13
KR - Corea 12
CL - Cile 11
UZ - Uzbekistan 11
EC - Ecuador 10
IR - Iran 10
MA - Marocco 10
PH - Filippine 10
CH - Svizzera 9
JM - Giamaica 9
AZ - Azerbaigian 8
PY - Paraguay 8
TN - Tunisia 8
IL - Israele 7
JO - Giordania 7
KE - Kenya 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
KZ - Kazakistan 6
NP - Nepal 6
LB - Libano 5
MY - Malesia 5
PE - Perù 5
AL - Albania 4
AT - Austria 4
DK - Danimarca 4
EG - Egitto 4
LT - Lituania 4
MK - Macedonia 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
MM - Myanmar 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
BZ - Belize 2
CR - Costa Rica 2
HN - Honduras 2
IS - Islanda 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
RE - Reunion 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
Totale 12.281
Città #
Singapore 881
Ashburn 617
Chandler 515
San Jose 467
Jacksonville 264
Dublin 214
San Mateo 214
Beijing 194
Wilmington 125
Jakarta 124
Nanjing 111
Ann Arbor 108
Lauterbourg 105
Hefei 89
Lawrence 89
Boston 88
Hanoi 74
Cattolica 73
Los Angeles 73
Dearborn 69
Ho Chi Minh City 64
Moscow 63
Tokyo 63
New York 62
Houston 61
Woodbridge 52
Fairfield 47
Redwood City 47
Boardman 46
Hong Kong 45
Seattle 44
Frankfurt am Main 43
São Paulo 42
Dallas 39
Buffalo 38
Detroit 37
Marseille 34
Mountain View 34
Helsinki 33
Kent 33
Nürnberg 33
Hangzhou 32
Lancaster 32
Nanchang 32
Shenyang 32
Milan 31
Munich 31
University Park 31
Rio de Janeiro 30
Chicago 29
Hebei 29
Santa Clara 29
Shanghai 29
Princeton 23
Izmir 22
Brussels 20
Bremen 19
Cambridge 19
Guangzhou 19
Norwalk 19
Jiaxing 18
Changsha 17
Rome 17
Baghdad 16
The Dalles 16
Washington 16
Da Nang 15
Paris 15
Tianjin 15
Brooklyn 14
Jinan 14
Kraków 14
London 14
Zhengzhou 14
Belo Horizonte 13
Council Bluffs 13
Pune 13
Fremont 12
Johannesburg 12
Ankara 11
Nuremberg 11
Brasília 10
Dhaka 10
Düsseldorf 10
Philadelphia 10
Simi Valley 10
Tashkent 10
Toronto 10
Warsaw 10
Curitiba 9
Denver 9
Jeddah 9
Kunming 9
Lahore 9
Leawood 9
Porto Alegre 9
Seoul 9
Stockholm 9
Busto Arsizio 8
Kingston 8
Totale 6.439
Nome #
Can vitamin a mediate immunity and inflammation? 181
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 176
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 168
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 159
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 157
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 155
Interleukin-6 in Rheumatoid Arthritis 155
Impact of mast cells in rejection of allografts 154
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 151
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 150
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 149
Reflux symptoms in wind instrument players. 143
The immune response to tumors as a tool toward immunotherapy 143
Role of vitamins D, E and C in immunity and inflammation. 143
IL-32: a newly-discovered proinflammatory cytokine 139
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 139
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 138
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 138
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 138
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 137
New insights on the role of T-cels in the pathogenesis of Celiac Disease 136
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 136
Third-line rescue therapy for Helicobacter pylori infection 135
New insights on the role of T cells in the pathogenesis of celiac disease. 131
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 129
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 129
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 128
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 126
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 126
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 125
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 125
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 123
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 123
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 122
Third-line rescue therapy for Helicobacter pylori infection. 118
TLR2: a crossroads between infections and autoimmunity? 115
Impact of IL-18 on inflammation 114
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 113
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 112
TLR2: a crossroads between infections and autoimmunity? 111
Luteolin inhibits mast cell-mediated allergic inflammation. 111
Current Challenges in Immunology 111
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 111
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 110
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 109
Activity of caffeic acid derivatives against Candida albicans biofilm 108
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 107
Impairment of recent thymic emigrants in HCV infection. 107
Strategies to overcome obstacles to successful immunotherapy of melanoma. 106
Impact of Fungi on Immune Responses 106
VEGF, substance P and stress, new aspects: a revisited study. 105
High prevalence of hyperplastic colonic polyps in acromegalic subjects 104
Mast cell involvement in rheumatoid arthritis. 104
Interrelationship between IL-3 and mast cells 104
The impact of biological agents interfering with receptor/ligand binding in the immune system. 103
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 103
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 102
Role of mast cells in innate and adaptive immunity. 101
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 99
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 99
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 99
Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation 97
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 96
Abnormal synthesis of IgA in coeliac disease and related disorderd 95
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 94
IL-31 a Th2 cytokine involved in immunity and inflammation. 94
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 93
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 93
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 93
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 93
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 93
Strategies to overcome obstacles to successful immunotherapy of melanoma 92
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 92
Involvment of central immunity in uncomplicated diverticular disease. 91
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 91
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 90
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 90
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 90
Impact of mast cells on the skin. 87
Nerve growth factor interactions with mast cells 87
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 85
Active thymopoiesis in idiopathic chronic pancreatitis 85
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 85
Vitamins and mast cells. 84
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 83
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 82
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 81
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 81
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 80
Epatite da farmaci 80
Impact of IL -9 and IL-33 in mast cells 80
Interrelationship between IL-3 and mast cells 79
Nutrition and cancer prevention 77
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 76
Impact of capsaicin on mast cell inflammation. 76
Nerve growth factor interactions with mast cells 76
IL-36 receptor antagonist with special emphasis on IL-38. 75
Allergic inflammation: role of cytokines with special emphasis on IL-4 75
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies 75
Totale 11.129
Categoria #
all - tutte 52.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 0 0 0 0 0 0 0 0 186 28
2021/2022881 65 128 15 63 47 34 11 127 39 44 118 190
2022/20231.587 233 182 156 207 156 203 55 94 166 44 60 31
2023/2024918 30 284 25 129 27 107 23 44 21 39 93 96
2024/20251.646 46 72 146 38 107 51 18 112 298 114 325 319
2025/20264.025 702 132 301 411 697 206 732 215 273 349 7 0
Totale 12.387